| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ae247397fa74fc3d12e48afb1dcc777d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
| filingDate |
2002-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e824848a340867da0a175b6a886b4974 |
| publicationDate |
2002-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-02067905-A1 |
| titleOfInvention |
A sustained release pharmaceutical formulation |
| abstract |
A sustained release pharmaceutical formulation is disclosed. The formulation comprises a water soluble medicament and a polymer mixture comprising a first component of about 80 weight percen polyvinylacetate combined with about 20 weight percen polyvinyl pyrrolidone, of the total weight of the first component, combined with a second component of a cellulose ether polymer. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2612501-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008004001-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005094831-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014197601-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008100249-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008004001-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022023808-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005018626-A1 |
| priorityDate |
2001-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |